Search
for
Sort by
Research 31–60 of 1000+
- Plasticity of differentiated cells in wound repair and tumorigenesis, part II: skin and intestine
- Characterisation of CD4+ stem cells of the skin and their role in skin homeostasis and tumourigenesis
- Molecular pathology of skin adnexal tumours
- Skin stem cells and tumor growth : functions of collagen XVIII in hair follicle cycling and skin cancer, and Bmx tyrosine kinase in tumor angiogenesis
- Multiple skin tumours in a Doberman Pinscher with colour dilution alopecia
- Cyclin D3 deficiency inhibits skin tumor development, but does not affect normal keratinocyte proliferation
- Chemically induced skin tumors arise from long-lived stem cells of the upper hair follicle
- Expression of androgen receptors in skin appendage tumors: An immunohistochemical study
- Lectin‐binding profiles for normal skin appendages and their tumors
- The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted
- Bone Morphogenetic Protein Antagonist Noggin Promotes Skin Tumorigenesis via Stimulation of the Wnt and Shh Signaling Pathways
- Fibrotic enzymes modulate wound‐induced skin tumorigenesis
- The Tumor Suppressor Actions of the Vitamin D Receptor in Skin
- Growth inhibition of mouse skin tumor by serine protease inhibitor ONO-3403.
- Study of clinicohistopathological correlation of skin adnexal tumours
- The Tumor Suppressor Actions of the Vitamin D Receptor in Skin
- Abstract 2469: Increased cathepsin B expression in cultured tuberous sclerosis skin tumor cells and patient tumor tissues
- Caffeine ameliorates radiation-induced skin reactions in mice but does not influence tumour radiation response
- Heterogeneity of ornithine decarboxylase expression in 12-<i>O</i>-tetradecanoylphorbol-13-acetate-treated mouse skin and in epidermal tumors
- Data from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Data from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin.
- Hair Follicle–Derived Blood Vessels Vascularize Tumors in Skin and Are Inhibited by Doxorubicin
- Expression of the hair stem cell-specific keratin 15 in pilar tumors of the skin.
- Tumor suppressor activity of ODC antizyme in MEK-driven skin tumorigenesis
- Meis1 Regulates Epidermal Stem Cells and Is Required for Skin Tumorigenesis
- Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Mitogen‐regulated protein/proliferin mRNA induction following single applications of tumor promoters to murine skin
- Elevated ornithine decarboxylase activity promotes skin tumorigenesis by stimulating the recruitment of bulge stem cells but not via toxic polyamine catabolic metabolites
- Basement Membranes in Experimentally Induced Skin Tumors